Despite the economic and political uncertainty in the recent past,
the global healthcare industry has been receiving positive nudges from
reformative and technological disruptions in medical devices,
pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging.
Key markets across the world are facing a massive rise in demand for
critical care services that are pushing global healthcare spending
levels to unimaginable limits.
A rapidly multiplying geriatric population; increasing prevalence of
chronic ailments such as cancer and cardiac disease; growing awareness
among patients; and heavy investments in clinical innovation are just
some of the factors that are impacting the performance of the global
healthcare industry. Proactive measures such as healthcare cost
containment, primary care delivery, innovation in medical procedures
(3-D printing, block chain, and robotic surgery to name a few), safe and
effective drug delivery, and well-defined healthcare regulatory
compliance models are targeted at placing the sector on a high growth
trajectory across key regional markets.
Parent Indicators Healthcare
Current expenditure on health, % of gross domestic product
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
Annual growth rate of current expenditure on health, per capita, in real terms
Out-of-pocket expenditure, % of current expenditure on health
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
Physicians, Density per 1000 population (head counts)
Nurses, Density per 1000 population (head counts)
Total hospital beds, per 1000 population
Curative (acute) care beds, per 1000 population
Medical technology, Magnetic Resonance Imaging units, total, per million population
Medical technology, Computed Tomography scanners, total, per million population
FMI utilizes a triangulation methodology that is primarily based on
experimental techniques such as patient-level data, to obtain precise
market estimations and insights on Molecule and Drug Classes, API
Formulations and preferred modes of administration. Bottom-up approach
is always used to obtain insightful data for the specific
country/regions. The country specific data is again analysed to derive
data at a global level. This methodology ensures high quality and
accuracy of information.
Secondary research is used at the initial phase to identify the age
specific disease epidemiology, diagnosis rate and treatment pattern, as
per disease indications. Each piece of information is eventually
analysed during the entire research project which builds a strong base
for the primary research information.
Primary research participants include demand-side users such as key
opinion leaders, physicians, surgeons, nursing managers, clinical
specialists who provide valuable insights on trends and clinical
application of the drugs, key treatment patterns, adoption rate, and
compliance rate.
Quantitative and qualitative assessment of basic factors driving
demand, economic factors/cycles and growth rates and strategies utilized
by key players in the market is analysed in detail while forecasting,
in order to project Year-on-Year growth rates. These Y-o-Y growth
projections are checked and aligned as per industry/product lifecycle
and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports,
investor presentations, SEC filings, 10k reports and press release
operating in this market segment to fetch substantial information about
the market size, trends, opportunity, drivers, restraints and to analyse
key players and their market shares. Key companies are segmented at
Tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed
while developing the market size. Besides this, forecasting will be done
based on our internal proprietary model which also uses different
macro-economic factors such as per capita healthcare expenditure,
disposable income, industry based demand driving factors impacting the
market and its forecast trends apart from disease related factors.
Standard Report Structure
Executive Summary
Market Definition
Macro-economic analysis
Parent Market Analysis
Market Overview
Forecast Factors
Segmental Analysis and Forecast
Regional Analysis
Competition Analysis
Market Taxonomy
The global ultrasound conductivity gels market has been segmented into:
We provide authentic and detailed an analysis on various market
trends to enable businesses to make informed and beneficial decisions to
attain competitive edge over key players.
Our analysts provide
detailed market segmentation along with meaningful insights and
extensive reports that other companies fail to include.
The
report includes accurate analysis of the market and the current
developing trends affecting the growth. FMI speaks to stakeholders
across the spectrum, including C-level executives, distributors, product
manufacturers, industry experts. This ensures that the data collected
is from highly reliable sources.
Explore Wide-ranging Coverage of FMI’sHealthcareMarket Insights Landscape
Biopsy Device Market –
Future Market Insights offers a one of its kind and a comprehensive
analysis of the global biopsy device market in its new publication
titled ‘Biopsy Device Market: Global Industry Analysis and and Review
Contrast-Enhanced Ultrasound Market– Contrast-Enhanced Ultrasound Market: Global Industry Analysis 2014 -2018 and Opportunity Assessment; 2019 – 2029
Veterinary Imaging Market – A recent market study published by Future Market Insights (FMI) on the Veterinary Imaging Market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, block chain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.
Parent Indicators Healthcare
Current expenditure on health, % of gross domestic product
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
Annual growth rate of current expenditure on health, per capita, in real terms
Out-of-pocket expenditure, % of current expenditure on health
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
Physicians, Density per 1000 population (head counts)
Nurses, Density per 1000 population (head counts)
Total hospital beds, per 1000 population
Curative (acute) care beds, per 1000 population
Medical technology, Magnetic Resonance Imaging units, total, per million population
Medical technology, Computed Tomography scanners, total, per million population
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Standard Report Structure
Executive Summary
Market Definition
Macro-economic analysis
Parent Market Analysis
Market Overview
Forecast Factors
Segmental Analysis and Forecast
Regional Analysis
Competition Analysis
Market Taxonomy
The global ultrasound conductivity gels market has been segmented into:
We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.
Explore Wide-ranging Coverage of FMI’sHealthcareMarket Insights Landscape
Biopsy Device Market – Future Market Insights offers a one of its kind and a comprehensive analysis of the global biopsy device market in its new publication titled ‘Biopsy Device Market: Global Industry Analysis and and Review
Contrast-Enhanced Ultrasound Market– Contrast-Enhanced Ultrasound Market: Global Industry Analysis 2014 -2018 and Opportunity Assessment; 2019 – 2029
Veterinary Imaging Market – A recent market study published by Future Market Insights (FMI) on the Veterinary Imaging Market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com